Biggest Short Squeeze Stocks Of The Week: Two Biotech Stocks Move Up To Top The List
Portfolio Pulse from Chris Katje
The top five short squeeze candidates for the week include Ambrx Biopharma, Tempest Therapeutics, Torrid Holdings, Bitcoin Depot, and Vapotherm. These stocks have high short interest and steep borrowing costs, common traits that could lead to a short squeeze. Ambrx Biopharma and Tempest Therapeutics, both biotech stocks, top the list.
October 31, 2023 | 2:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ambrx Biopharma tops the short squeeze leaderboard, moving up 4,104 positions from the previous week. 88.4% of the float is short and a cost to borrow of 27.6%.
With a high percentage of the float short and a significant cost to borrow, Ambrx Biopharma is a prime candidate for a short squeeze, which could drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Bitcoin Depot ranks fourth on the short squeeze list, falling two positions from last week. 15.2% of the float is short and a cost to borrow of 31.2%.
Bitcoin Depot has a high short interest and a significant cost to borrow, making it a potential target for a short squeeze, which could result in a rapid increase in its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Torrid Holdings ranks third on the short squeeze list, moving up two positions from the previous week. 21.7% of the float is short and a cost to borrow of 28.1%.
With a high short interest and a significant cost to borrow, Torrid Holdings could be subject to a short squeeze, which could lead to a sharp rise in its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Tempest Therapeutics ranks second on the short squeeze list, moving up 1,414 positions from the previous week. 28.1% of the float is short and a cost to borrow of 119.3%.
Tempest Therapeutics has a high short interest and a steep cost to borrow, making it a potential target for a short squeeze, which could result in a rapid increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Vapotherm ranks fifth on the short squeeze leaderboard, moving up 14 positions from the previous week. 11.2% of the float is short and a cost to borrow of 14.1%.
Vapotherm has a high short interest and a significant cost to borrow, making it a potential target for a short squeeze, which could result in a rapid increase in its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100